* Phibro Animal Health Corp PAHC.OQ reported quarterly
adjusted
earnings of 41 cents per share for the quarter ended June 30,
higher than the same quarter last year, when the company
reported EPS of 38 cents. The mean expectation of
three analysts for the quarter was for earnings of 33 cents per
share. Wall Street expected results to range from 33 cents to 34
cents per share.
* Revenue rose 7.1% to $273.20 million from a year ago;
analysts
expected $263.25 million.
* Phibro Animal Health Corp's reported EPS for the quarter
was 2
cents.
* The company reported quarterly net income of $752
thousand.
* Phibro Animal Health Corp shares had risen by 25.6% this
quarter and gained 81.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "sell"
Wall Street's median 12-month price target for Phibro Animal
Health Corp is 13.00
This summary was machine generated from LSEG data August 28 at
09:41 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.33 0.41 Beat
Mar. 31 2024 0.29 0.31 Beat
Dec. 31 2023 0.28 0.33 Beat
Sep. 30 2023 0.23 0.14 Missed